Completed
Clinical Trial for Measles - Rubella Combined Vaccine (MRVAC) Produced by POLYVAC (Phase III)
NCT03713359
- Conditions
- Body Temperature Changes, Exanthema, Fever, +4 more
- Locations
-
Not specified